Anitrazafen
Chemical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H17N3O2 |
Molar mass | 307.353 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Anitrazifen is a drug displaying COX-2 inhibitor activity.[1]
References
[edit]- ^ Cullen E (May 1984). "Novel anti-inflammatory agents". Journal of Pharmaceutical Sciences. 73 (5): 579–89. doi:10.1002/jps.2600730503. PMID 6429314.
pyrazolones / pyrazolidines | |
---|---|
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
Receptor (ligands) |
| ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enzyme (inhibitors) |
| ||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |